(Q46882764)

26 December 2017

title

A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection (English)

1 reference

26 December 2017

1 reference

Timothy H Mathew

1

1 reference

26 December 2017

Charles Van Buren

2

1 reference

26 December 2017

Barry D Kahan

3

1 reference

26 December 2017

Khalid Butt

4

1 reference

26 December 2017

Sundaram Hariharan

5

1 reference

26 December 2017

James J Zimmerman

6

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

46

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

76-87

1 reference

26 December 2017

Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

DETERMINANTS OF GRAFT SURVIVAL AFTER RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005282628

21 January 2018

Identifiers

DOI

10.1177/0091270005282628

1 reference

26 December 2017

1 reference

26 December 2017